Icon

RIVFLOZA (NDA215842)- (EQ 80MG BASE/0.5ML (EQ 160MG BASE/ML),EQ 128MG BASE/0.8ML (EQ 160MG BASE/ML),EQ 160MG BASE/ML (EQ 160MG BASE/ML))

NEDOSIRAN SODIUM NOVO
EQ 80MG BASE/0.5ML (EQ 160MG BASE/ML),EQ 128MG BASE/0.8ML (EQ 160MG BASE/ML),EQ 160MG BASE/ML (EQ 160MG BASE/ML)
No No
2038-Oct-12 2028-Sep-29
None None
None No
RIVFLOZA is an LDHA-directed small interfering RNA indicated to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥ 30 mL/min/1.73 m2.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 80MG BASE/0.5ML (EQ 160MG BASE/ML) ** ** - - -
EQ 128MG BASE/0.8ML (EQ 160MG BASE/ML) ** ** - - -
EQ 160MG BASE/ML (EQ 160MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.